Join Business Exchange
to access the mostrelevant content for you,
filtered by like-mindedbusiness professionals.
Boston Scientific Corp. yesterday said it has agreed to pay $296 million to settle a US Department of Justice investigation into charges that its Guidant heart-device subsidiary made faulty product reports...
to access the most relevant content for you, filtered by like-minded business professionals.
About Business Exchange
Send us Feedback
©2013 Bloomberg L.P. All Rights Reserved.